Organon (OGN) Net Cash Flow (2020 - 2026)

Organon (OGN) has reported Net Cash Flow for 7 consecutive years, with $573.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Cash Flow rose 433.14% year-over-year to $573.0 million; the TTM figure through Mar 2026 stood at $494.0 million (up 2570.0% YoY), while the FY2025 annual figure was -$251.0 million, down 532.76% from the prior year.
• Net Cash Flow came in at $573.0 million for Q1 2026 at Organon, up from -$111.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $573.0 million in Q1 2026, with the low at -$266.0 million in Q1 2023.
• Average Net Cash Flow over 5 years is $20.9 million, with a median of -$12.0 million recorded in 2024.
• The largest YoY upside for Net Cash Flow was 708.33% in 2025 against a maximum downside of 1025.0% in 2025.
• Year by year, Net Cash Flow stood at $124.0 million in 2022, then soared by 92.74% to $239.0 million in 2023, then sank by 94.98% to $12.0 million in 2024, then tumbled by 1025.0% to -$111.0 million in 2025, then jumped by 616.22% to $573.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $573.0 million, -$111.0 million, and $73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.